Trial Profile
Systemic Cardiovascular Effects of Intravenous Urocortin 2 and Urocortin 3 in Patients with Heart Failure and Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Apr 2015
Price :
$35
*
At a glance
- Drugs Urocortin 2 (Primary) ; Urocortin 3 (Primary) ; Sodium nitroprusside
- Indications Heart failure
- Focus Pharmacodynamics
- 27 Apr 2015 New trial record